Research Scientist - Virology HBV/HDV Cure

Foster City, CA
Nov 25, 2021
Biotech Bay
Required Education
Position Type
Full time
Research Scientist - Virology HBV/HDV Cure
United States - California - Foster City

Gilead Sciences, Inc. is a research-based bio-pharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we seek to improve the care of patients living with life-threatening diseases around the world. Gilead’s therapeutic areas of focus include HIV/AIDS, liver diseases, cancer and inflammation, and serious respiratory and cardiovascular conditions.

Making an impact on a global scale
Inclusion is one of the company’s five core values. That’s because we know that we are stronger and more innovative at Gilead when we are informed by a diverse set of backgrounds, experiences and points of view. Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide.

When you join Gilead, you join our mission to change the world by enabling people to live healthier and more fulfilling lives. Come join a mission-driven bio-pharmaceutical organization that values inclusion and diversity, has a strong portfolio of products, and is constantly #CreatingPossible

We are seeking a highly motivated and creative scientist with expertise in virology and immunology to take a leading role in our internal research efforts to support drug development for a functional cure of chronic HBV, and/or HDV infection. The successful candidate will support drug development efforts in the area of HBV/HDV cure. To support these programs, the RS will be responsible for developing new virology biomarkers, characterizing drug resistance, and investigating mechanism of action of new inhibitors. In addition, he/she will be the virology lead for ongoing HBV and HDV preclinical and clinical studies. To contribute to the clinical studies, this position will conduct assay development, resistance analyses, write documents for regulatory submissions (IND/NDA), and prepare publication/ presentation of results.

Essential Functions:
  • Develop biomarkers for novel HBV cure modalities including new antivirals, targeted and immune-based therapies.
  • Identify and lead relevant external collaborations in areas applicable to HBV/HDV cure.
  • Lead virology monitoring and characterization of drug resistance of novel compounds in the clinic
  • Build strong internal scientific expertise in vitro HBV/HDV infection models and introduce new tools, assays, and models relevant to HBV/HDV infection and treatment
  • Contribute to clinical studies through supporting regulatory submissions

Knowledge, Experience and Skills:
  • PhD or equivalent degree in virology or relevant scientific discipline and a minimum of 2 years of post-doctoral experience
  • In-depth knowledge of virology, molecular biology and/or immunology preferred. Previous experience studying immune responses to viral infections is a plus.
  • A strong applicant will have extensive skill sets in cell biology, molecular biology and assay development -Excellent written and oral communication skills
  • Strong motivation, independence, and ability to work in a high-pace multidisciplinary environment with minimal supervision
  • Ability to think independently and fully integrate into a high achieving team environment

For jobs in the United States:

As an equal opportunity employer, Gilead Sciences Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact for assistance.

Following extensive monitoring, research, consideration of business implications and advice from internal and external experts, Gilead has made the decision to require all U.S. employees and contractors to receive the COVID-19 vaccines as a condition of employment. “Full vaccination” is defined as two weeks after both doses of a two-dose vaccine or two weeks since a single-dose vaccine has been administered. Anyone unable to be vaccinated, either because of a sincerely held religious belief or a medical condition or disability that prevents them from being vaccinated, can request a reasonable accommodation.​

For more information about equal employment opportunity protections, please view the ‘EEO is the Law' poster.



Our environment respects individual differences and recognizes each employee as an integral member of our company. Our workforce reflects these values and celebrates the individuals who make up our growing team.

Gilead provides a work environment free of harassment and prohibited conduct. We promote and support individual differences and diversity of thoughts and opinion.

For Current Gilead Employees and Contractors:

Please log onto your Internal Career Site to apply for this job.